1093733-09-5Relevant articles and documents
Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer
Chen, Ying,Foss, Catherine A.,Byun, Youngjoo,Nimmagadda, Sridhar,Pullambhatla, Mrudula,Fox, James J.,Castanares, Mark,Lupold, Shawn E.,Babich, John W.,Mease, Ronnie C.,Pomper, Martin G.
experimental part, p. 7933 - 7943 (2009/12/07)
To extend our development of new imaging agents targeting the prostate-specific membrane antigen (PSMA), we have used the versatile intermediate 2-[3-(5-amino-1-carboxy-pentyl)-ureido]-pentanedioic acid (Lys-C(O)-Glu), which allows ready incorporation of